• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Briacell Therapeutics Corp WT (NQ: BCTXW )

    0.3198 -0.0252 (-7.30%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Oct 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 328,661
    Open 0.3030
    Bid (Size) 0.2900 (6)
    Ask (Size) 0.3300 (4)
    Prev. Close 0.3450
    Today's Range 0.2812 - 0.3895
    52wk Range 0.1055 - 2.600
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers
    From my analysis of BriaCell, it would make a great buy and hold investment. If, and when, it is bought out by a major pharmaceutical company, or brings a product directly to market itself, its stock... 
    Via Talk Markets
    BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer
    Registration study success could lead to a Biologics License Application (BLA) submission and commercialization approvals for BriaCell’s novel immunotherapy approach. 
    Via Talk Markets

    Performance

    YTD
    -86.68%
    -86.68%
    1 Month
    +38.14%
    +38.14%
    3 Month
    +57.23%
    +57.23%
    6 Month
    -70.39%
    -70.39%
    1 Year
    -84.77%
    -84.77%

    More News

    Read More
    BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
    Via News Direct
    Topics Death
    Exposures Death
    BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
    Via TheNewswire.com
    Topics Death
    Exposures Death
    BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
    Via Benzinga
    BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
    Via Benzinga
    IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
    From ImmunoPrecise Antibodies
    Via Business Wire
    Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
    From Stock News Now
    Via AccessWire
    Topics Cannabis
    Exposures Cannabis
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.